VNDA(Vanda Pharmaceuticals Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $268.68M | $254.38M | $192.64M | $198.77M | $216.10M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $42.16M | $6.33M | −$13.95M | −$40.66M | −$151.17M |
| 净利润 | $33.15M | $6.28M | $2.51M | −$18.90M | −$220.47M |
| 经营现金流 | $64.21M | $31.98M | $12.80M | −$15.76M | −$109.44M |
| 自由现金流 | $63.66M | $31.30M | $12.42M | −$16.25M | −$110.44M |
| 摊薄每股收益 | $0.58 | $0.11 | $0.04 | $-0.33 | $-3.74 |